Based off a pic I found on Pinterest
Game of Thrones Daily
Three Goblin Art
No title available
ojovivo
Stranger Things

izzy's playlists!
Not today Justin

Discoholic šŖ©
Mike Driver
Peter Solarz
Aqua Utopiaļ½ęµ·ć®åŗć§čØę¶ćē“”ć
Show & Tell
Claire Keane

Kaledo Art
taylor price
sheepfilms
trying on a metaphor

ē„ę„ / Permanent Vacation
Today's Document
"I'm Dorothy Gale from Kansas"

seen from Australia
seen from Peru
seen from Netherlands
seen from United States
seen from Canada

seen from Italy
seen from United States
seen from United Kingdom

seen from Malaysia

seen from Indonesia

seen from Malaysia
seen from Australia
seen from Netherlands
seen from United States
seen from United States
seen from United States

seen from Singapore
seen from Malaysia
seen from Ecuador

seen from Malaysia
@proxymagic
Based off a pic I found on Pinterest
burnout sucks!! getting back into it though
I saw a comment that said "a very in-depth injury system functionally necessitates a very in-depth care system", and it's been stuck in my mind for over a week now so I drew this out for it
anyways casualties unknown is lovely
( Ė Ā³Ė)āæā§āĖā¹āā” the serial smoocher
source: Adedire Abiodun
Theyāre calling me every slur under the sun over on twitter for this post
Would you sell liquor to this baby
Yes
No
I donāt think life begins at contraception but Iād still sell liquor to baby
Wait hold on rb canceled thatās the wrong word wait no stopļæ¼
gay meth
WHAT IS THE DIFFERENCE,?
SIKEĀ
Catch me dead in that iTomb
#Levels
Video games š®
dog off the leash
For millions of people managing type 2 diabetes, mornings begin the same way ā a needle, a dose, and a quiet mental note to do it all again
For millions of people managing type 2 diabetes, mornings begin the same way ā a needle, a dose, and a quiet mental note to do it all again tomorrow.
That routine just changed.
On March 26, 2026, the U.S. Food and Drug Administration approved Awiqli (insulin icodec-abae), developed by Novo Nordisk, as the first and only once-weekly basal insulin ever approved for adults with type 2 diabetes in the United States.
This is not a minor update to an existing drug.
It is the first entirely new class of basal insulin to reach U.S. patients in more than two decades.
Instead of injecting insulin every single day, people with type 2 diabetes using Awiqli will only need one shot per week, on the same day, every week.
That means reducing from 365 injections a year down to just 52.
For anyone who has ever felt the weight of that daily ritual ā the anxiety of forgetting, the physical discomfort, the constant reminder that their body needs help ā this approval represents something much bigger than a dosing schedule.
It represents relief.
How the Drug Actually Works
Understanding why this injection lasts a full week requires a quick look inside the body.
Most traditional basal insulins are absorbed into the bloodstream and begin breaking down within 24 hours, which is why patients need a fresh dose every day to maintain stable blood sugar levels.
Awiqli works differently.
Its active ingredient, insulin icodec-abae, is engineered to loosely attach to a blood protein called albumin, which is found naturally and abundantly in the bloodstream.
This attachment creates a slow-release reservoir.
Instead of flooding the system and fading fast, the insulin releases gradually and consistently over an entire seven-day period, keeping blood sugar in a healthy range around the clock...
The FDA reviewed and ultimately declined to approve it for people with type 1 diabetes, citing concerns about a modestly increased risk of hypoglycemia in that population specifically.
Some regulatory agencies in other countries, including the European Union, Canada, Australia, and Japan, have approved Awiqli for both type 1 and type 2 diabetes, but for now the U.S. approval is limited to type 2...
What Comes Next
Awiqli is not standing alone in this space for long.
Eli Lilly is developing its own once-weekly basal insulin, called efsitora alfa, which is currently in late-stage clinical trials.
If that drug also earns FDA approval, it would give patients and doctors two once-weekly options to choose from, allowing for personalized decisions based on a patientās health profile, insurance coverage, and individual response.
The broader direction of travel in diabetes care is unmistakable.
Fewer injections, smarter formulations, and better integration with digital tools like continuous glucose monitors and insulin-tracking apps are all converging toward a future where managing diabetes requires less daily mental effort without becoming any less medically precise...
A Small Shot With Large Implications
It is easy to look at a once-weekly injection and see only a scheduling change.
But the science behind Awiqli, the scale of the ONWARDS trials, and the consistent satisfaction reported by patients all point toward something that matters far more than convenience.
Diabetes management has always asked a lot of people.
It asks for daily vigilance, daily discipline, and a daily willingness to confront oneās own condition, sometimes in uncomfortable or inconvenient circumstances.
Anything that reduces that load, without reducing the quality of care, is worth taking seriously.
For the more than 37 million Americans living with diabetes, and the hundreds of millions more around the world, a simpler weekly routine could mean the difference between a treatment plan that works on paper and one that actually works in a personās life.
That is the real significance of what the FDA approved on March 26, 2026.
Not just a new drug.
A new way of keeping people healthy, one week at a time.
-via Science Aim, March 29, 2026.
We're getting there little by little, sure. But it's a road.
Anyway happy international asexuality day back to work I go
I actually dont think asking for someones pronouns putting them on the spot is a very thoughtful thing to do
You could just be chill until you find out idk it is an impatient way to go about forming human relationships and its happened to me irl so many times with people staring at me with big smiles and eyes as they wait for me to oblige them so they know how to treat me
But like you aren't owed that information like it is so disconnecting and uncaring
People judge each other on social skills but the social expectation of answering this question is just garbage.
If you insist you cant interact unless you know someone's pronouns that is a skill issue